Chicago, May 27, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026", published by MarketsandMarkets™, is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%.
Browse in-depth TOC on "eClinical Solutions Market"
228 - Tables
38 - Figures
234 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=553
Increasing operational costs and regulatory requirements associated with clinical research studies;
The medical research and novel drug therapy industry is witnessing a shift from traditional drug-based treatment towards personalized or gene-based disease management. Government reimbursement bodies and private insurers & and payers often demand better therapeutic value and higher efficacy for novel drugs as compared to existing alternative therapies or medications. Moreover, these payer regulate standard pricing of novel medications, thereby lowering profit margins for manufacturing companies. The eClinical solutions industry is focusing on the enhancement & commercialization of software solutions that can facilitate early execution and completion of clinical trials in a cost-effective manner. Major pharmaceutical and biotechnology companies are adopting new business models to reduce their overall research cost, which is expected to drive the market demand for advanced and innovative eClinical solutions.
Cloud-based (SaaS) segment is projected to record the highest CAGR
On the basis of delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions. In 2020, the web-hosted (on-demand) segment commanded the largest share (55.4%) of the global eClinical solutions market. However, the cloud-based (SaaS) segment is projected to record the highest CAGR (17.8%) in the forecast period. The increasing number of cloud-based clinical trial solutions in the market and the rising adoption of these solutions in clinical research studies (owing to advantages such as ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee) are fueling the growth of the cloud-based eClinical solutions market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=553
Scope of the eClinical Solutions Market
| Report Metrics | Details |
| Market size available for years | 2022–2026 |
| Base year considered | 2020 |
| Largest Market | North America |
| Forecast Period 2022-2026 CAGR | 13.3% |
| Estimated Year Market Size | USD 8.3 billion |
| Forecast Year Market Size | USD 15.4 billion |
| Segments covered | By Product, By Delivery mode, By Clinical trials phases, By End User & By Region |
| Geographies covered | North America, Europe, Asia Pacific, ROW |
| Companies covered | Oracle Corporation (US), Medidata Solutions, Inc. (US), Parexel International Corporation (US), BioClinica, Inc. (US), Signant Health (US), Datatrak International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US) and others. |
Phase III clinical trials is expected to register the highest growth during the forecast period
On the basis of clinical trial phase, the eClinical solutions market has been segmented into phase I, phase II, phase III, and phase IV trials. The phase III clinical trials segment accounted for the largest share (52.0%) of the eClinical solutions market in 2020. The large share of this segment is attributed to the high demand for eClinical solutions for phase III trials due to the involvement of thousands of patients in this phase.
CROs segment is estimated to record the highest CAGR in the forecast period.
On the basis of end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions. The pharmaceutical and biopharmaceutical companies segment accounted for the largest share (38.4%) of the eClinical solutions market in 2020. However, the CROs segment is estimated to record the highest CAGR (15.5%) in the next five years. The increasing number of CROs in developed as well as developing countries, and the rising instances of clinical trial outsourcing to specialized clinical research organizations are responsible for the high growth rate of this segment.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=553
North America to Witness Significant Growth from 2021 To 2026
North America commanded the largest share (60.1%) of the eClinical solutions market in 2020. Increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, and growth in the number of partnerships for new drug development are further stimulating the demand for eClinical solutions in this region. Europe accounted for the second-largest share of the global eClinical solutions market in 2020. This can be attributed to the large number of ongoing clinical trials and rising investments by pharmaceutical and biopharmaceutical companies to support their drug development pipeline.
Key Players
- Oracle Corporation (US)
- Medidata Solutions, Inc. (US)
- Parexel International Corporation (US)
- BioClinica, Inc. (US)
- Signant Health (US)
- Datatrak International, Inc. (US)
- ERT (US)
- eClinical Solutions, Inc. (US)
- MaxisIT Inc. (US)
- Bio-Optronics, Inc. (US)
- Merge Healthcare Incorporated (US)
- OmniComm Systems, Inc. (US)
Oracle Corporations is one of the top players in the global eclinical solutions market in 2020. The company’s robust product portfolio and diversified geographic presence and customer base contributes to its position in the market. Oracle Corporation primarily focuses on product developments and launches to expand its footprint in the global market. It company also focuses on collaborations and alliances with leading biopharma companies to enhance its customer base across the globe.
Browse Adjacent Markets @ Healthcare IT Market Research Reports & Consulting
Browse Related Reports:
Healthcare Analytics Market by Type (Descriptive, Prescriptive, Cognitive), Application (Financial, Operational, RCM, Fraud, Clinical), Component (Services, Hardware), Deployment (On-premise, Cloud), End-user (Providers, Payer) - Global Forecast to 2026
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV), Type (Small molecule, Biologics, Medical Devices) Therapeutic Areas (Oncology, CNS, CVD, Infectious, Immunology) - Global Forecast 2026
Inquire Now: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=553
